Workflow
US Stocks Mixed; Sea Shares Gain After Q3 Results
Benzinga·2025-11-11 14:40

Market Overview - U.S. stocks showed mixed performance with the Nasdaq Composite falling over 0.4% on Tuesday, while the Dow increased by 0.13% to 47,430.01 and the S&P 500 dropped 0.15% to 6,823.18 [1] - Energy shares rose by 0.9%, while information technology stocks decreased by 0.7% [1] Company Performance - Sea Ltd (NYSE:SE) shares increased by approximately 4% after reporting fiscal Q3 2025 results, with revenue rising 38.3% year-on-year to $5.99 billion, surpassing analyst expectations of $5.65 billion. However, earnings per share were 59 cents, missing the consensus forecast of 77 cents [2] Commodity Market - Oil prices increased by 1.1% to $60.76, gold rose by 0.7% to $4,151.60, silver went up by 1.4% to $51.030, while copper fell by 0.3% to $5.0915 [5] European Market - European shares experienced gains, with the eurozone's STOXX 600 rising by 0.8%, Spain's IBEX 35 Index gaining 0.8%, London's FTSE 100 increasing by 0.8%, Germany's DAX 40 up by 0.2%, and France's CAC 40 climbing by 0.9% [6] Asian Market - Asian markets closed mixed, with Japan's Nikkei 225 down by 0.14%, Hong Kong's Hang Seng up by 0.18%, China's Shanghai Composite declining by 0.39%, and India's BSE Sensex rising by 0.40% [7] Notable Stock Movements - MSP Recovery Inc (NASDAQ:MSPR) shares surged 104% to $0.65 after a previous decline of 15% [9] - Quoin Pharmaceuticals Ltd – ADR (NASDAQ:QNRX) shares increased by 51% to $12.47 following the achievement of target loadings for proprietary delivery technologies [9] - Surmodics Inc (NASDAQ:SRDX) shares rose by 50% to $41.08 after a court denied the FTC's bid to block an acquisition [9] - Vor Biopharma Inc (NASDAQ:VOR) shares dropped 48% to $9.87 due to a public offering announcement of $100 million [9] - Salarius Pharmaceuticals Inc (NASDAQ:SLRX) shares fell 50% to $1.00 after announcing a $7 million public offering [9] - Outset Medical Inc (NASDAQ:OM) shares decreased by 42% to $7.04 after reporting worse-than-expected Q3 results and cutting FY25 sales guidance [9]